A Novel Classification Model Based on Hyperspectral Imaging for Predicting Response to Tacrolimus in Patients With Primary Membranous Nephropathy
Journal of Biophotonics · 2025
DOI: 10.1002/jbio.70025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biophotonics, 2025. Verfasst von Meijuan Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Inst…. Hauptthemen laut MEDLINE: Tacrolimus, Glomerulonephritis, Membranous, Hyperspectral Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: "PRO•Run"Fund of the Nephrology Group of CEBM (KYJ202206-0003-10), China International Medical Foundation (Z-2017-26-2202-4), Natural Science Foundation of Shandong Province (ZR2023MH255).
Abstract (Originalsprache)
At present, the research to predict the efficacy of tacrolimus (TAC) mainly focuses on serological indexes and urine analysis. Because these indicators are affected by many factors, they cannot accurately predict the therapeutic effect of primary membranous nephropathy (PMN) patients. In this study, a novel classification model (RCN) based on hyperspectral imaging combined with one‐dimensional convolutional neural networks (1D CNN) and relevance vector machine (RVM) was proposed for predicting patients' response to TAC. Based on the treatment outcomes of corticosteroids combined with TAC, the patients were divided into a remission group and a nonremission group. Through the analysis of hyperspectral data of pathological slices of patients in both the remission group and the nonremission group, the research results show that the model can effectively extract key features from the spectral data and achieve high classification performance, and it can predict the therapeutic effect of TAC in PMN patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Nephrology, Jinan, China.
- School of Control Science and Engineering, Shandong University, Jinan, China.
- School of Radiology, Shandong First Medical University, Taian, China.
- Marine and Freshwater Biology, College of Life Sciences, University of Glasgow, Glasgow, Scotland.
ORCID-Profile: Zunsong Wang
Förderung
- "PRO•Run"Fund of the Nephrology Group of CEBM (KYJ202206-0003-10)
- China International Medical Foundation (Z-2017-26-2202-4)
- Natural Science Foundation of Shandong Province (ZR2023MH255)
- Qilu Health and Wellness Leading Talents Project
- Clinical Medical Research Promotion Program Foundation (2024CMFA01)
Zitieren
APA
Sun, M., Zhang, W., Tian, C., Wang, R., Liu, W., Li, Y., Lv, Y., & Wang, Z. (2025). A Novel Classification Model Based on Hyperspectral Imaging for Predicting Response to Tacrolimus in Patients With Primary Membranous Nephropathy. Journal of Biophotonics. https://doi.org/10.1002/jbio.70025
Vancouver
Sun M, Zhang W, Tian C, Wang R, Liu W, Li Y, et al. A Novel Classification Model Based on Hyperspectral Imaging for Predicting Response to Tacrolimus in Patients With Primary Membranous Nephropathy. Journal of Biophotonics. 2025. doi:10.1002/jbio.70025
BibTeX
@article{Sun2025,
author = {Sun, Meijuan and Zhang, Wenqiang and Tian, Chongxuan and Wang, Ruiyang and Liu, Wen and Li, Yang and Lv, Yang and Wang, Zunsong},
title = {A Novel Classification Model Based on Hyperspectral Imaging for Predicting Response to Tacrolimus in Patients With Primary Membranous Nephropathy},
journal = {Journal of Biophotonics},
year = {2025},
doi = {10.1002/jbio.70025}
}
EUVIMED